Download Free Medical Good Manufacturing Practices in a Quality World PowerPoint Presentation

Good Manufacturing Practices in a Quality World PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "GOOD MANUFACTURING PRACTICES IN A QUALITY WORLD" by Gordon Harnack.

This medical PowerPoint presentation is about Good Manufacturing Practices (GMP), a set of guidelines that define the requirements for the production of pharmaceuticals, medical devices, and other healthcare products. The goal of GMP is to ensure that the products are consistently produced and controlled to meet the quality standards appropriate for their intended use.

GMP guidelines cover all aspects of the manufacturing process, including facilities, equipment, materials, personnel, documentation, and quality control.

By following GMP guidelines, pharmaceutical manufacturers can ensure that their products are safe, effective, and of high quality. GMP is enforced by regulatory agencies such as the FDA and EMA, and non-compliance can result in serious consequences such as product recalls, fines, and legal action.

Tags : Good Manufacturing Practices, production of pharmaceuticals, production of medical devices, pharmaceuticals, pharmaceuticals PowerPoint presentations

Published on : Jun 23, 2023 | Views : 2029 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

1 GOOD MANUFACTURING PRACTICESIN A QUALITY WORLD Gordon Harnack President, Oracle Consulting Group Tucson, AZ www.fdamaze.com
Slide 2-

2 The Discussion Plan Definitions General Discussion Drugs Devices In Vitro Diagnostics Food Cosmetics GMP Specifics – Device GMPs
Slide 3-

3 What are Good Manufacturing Practices (GMP)? Good Manufacturing Practice regulation is a set of regulations, codes, and guidelines for the manufacture of drugs (known as medicinal products in Europe), medical devices, diagnostic products, foods products and Active Pharmaceutical Ingredients (APIs). http://en.wikipedia.org/wiki/Good_Manufacturing_Practice
Slide 4-

4 What are Current Good Manufacturing Practices (cGMP)? Good Manufacturing Practice implemented in 1976 for the manufacture of products that are under FDA jurisdiction, including pharmaceuticals, biological products and medical devices. Current Good Manufacturing Practice ensures that finished products have the correct identity, strength, quality and purity characteristics they are represented to have, and have not been altered during processing, packaging, or handling. It requires extensive use of documentation and strict reconciliation of inventory. www.sciteclabs.com/dictionary.html
Slide 5-

5 Why GMP Regulations? The Federal Food, Drug & Cosmetic Act authorizes such regulations Title 21, Chapter 9, FFD&C Act has 17 references to GMPs FDA’s mechanism to implement oversight of any “manufacturing” operation Establishes FDA’s “minimal” manufacturing control expectations Make management the chief “jailable” officer Absent GMP regulations – fall back on FFDC Act!
Slide 6-

6 FDA’S ExpectationsRelated to Firm Size The larger the firm the greater FDA expectations However, even the smallest firm MUST address every aspect of applicable FDA regulations.
Slide 7-

7 What FDA Centers deal with Drug GMPs? Center for Biologics Evaluation & Research (CBER) Center for Drug Evaluation & Research (CDER) Center for Veterinary Medicine (CVM) CDER states: “Useful to manufacturers of components used in the manufacture of these products”
Slide 8-

8 What Types of Firms are Exempt from Drug GMPs? Drug wholesalers, retailers, pharmacies & hospitals unless engaged in manufacturing operations beyond the usual dispensing or selling of drugs at retail Compounders of drugs – pharmacists & physicians Note: Compounded drugs must still be composed of FDA approved components. Note: Some products are exempt from certain elements of Drug GMP.
Slide 9-

9 What Types of Firms are Exempt from Drug GMP Regulations? (cont) Manufacturers of active pharmaceutical ingredients (APIs) & bulk drugs are exempt from cGMP REGULATIONS but NOT cGMP requirements of the FFDC Act! FDA cites API manufacturers for violations of the ACT, not drug GMP regulations FDA’s GMP regulations are used as “guidance” during inspections. FDA claims to be working on specific API GMPs
Slide 10-

10 Drug GMPs Apply to Prescription & OTC drugs, including homeopathic drugs Manufacturing facilities of ALL sizes Investigational drugs for clinical trials Foreign produced drugs distributed in the U.S.
Slide 11-

11 Drug GMPs 21 CFR § 210 - cGMP in Manufacturing, Processing, or Holding of Drugs; General 21 CFR 211 - cGMP Practice for Finished Pharmaceuticals 21 CFR 210 & 211 – 300+ “shalls”
Slide 12-

12 Drug GMPs (continued) Applicability GMP of §’s 210 – 226 & §’s 600 – 680 supplement – not supersede each other, unless otherwise directed Compliance failures  adulterated drug product
Slide 13-

13 Drug GMPs (continued) Proposed new drug cGMPs will model FDA’s intent to integrate QS & RISK MANAGEMENT…& to harmonize with other non-drug regulatory systems & ISO 9000 FDA states that a robust modern QS must embrace the concept that: “Quality should be built into the product, and testing alone cannot be relied on to ensure product quality.”
Slide 14-

14 Drug GMPs (continued) GMP Regulations specific to CBER regulated products 21 CFR 606 – Current GMP for blood & blood products 21 CFR 610 – General biological products standards 21 CFR 630 – General requirements for blood, blood components & blood derivatives 21 CFR 640 – Additional standards for human blood and blood products 21 CFR 660 – Additional standards for diagnostic substances for laboratory tests 21 CFR 680 – Additional standards for miscellaneous products
Slide 15-

15 Medical Device GMPs QUALITY SYSTEM REGULATIONS 21 CFR § 820 - 200+ “shalls” Control each phase of manufacturing Harmonized with ISO 9000 Greater emphasis on compliant handling, corrective & preventive actions, & labeling
Slide 16-

16 What Types of Firms are Exempted from Device GMPs? Component manufacturers Note: Some individual TYPES of devices are exempt from some elements of GMP regulations, for example: Many Class I devices, like tongue depressors, are typically exempted from all GMPs except records (820.180) & complaint files (820.198).
Slide 17-

17 In Vitro Devices GMPs 21 CFR 809 – In vitro diagnostic products for human use - approximately 25 “shalls”
Slide 18-

18 Cosmetic GMPs – No Specific GMP Regulations Regulated under the FFDC Act for: Labeling Ingredients Contaminants Processing Packaging, or Shipping and handling
Slide 19-

19 Current Good Food Manufacturing Practices 21 CFR 110 – approximately 95 “shalls” Focus on Sanitary/Unsanitary conditions Personnel, Equipment & Buildings Production/Process Controls Raw materials Water Storage Warehousing & distribution
Slide 20-

20 Now a Close Examination of Medical Device GMPs
Slide 21-

21 What Types of Firms are Subject to Device GMPs? Remanufacturers Custom Device Manufacturers Contract Manufacturers Contract Testing Labs Repackagers, Relabelers & Specification Developers Manufacturers of Accessories Initial Distributors
Slide 22-

22 Medical Device GMP20 Elements Management responsibility Quality system controls Training controls Design/Development controls Document & data controls Purchasing controls Product identification & traceability controls Process and manufacturing controls Inspection & testing controls Inspection, measuring, & test equipment controls Process Validation Labels & Labeling Acceptance controls Non-conforming product controls Corrective & preventive action controls Handling, storage, packaging, preservation & delivery controls Quality record controls Installation & Servicing controls Complaint Handling controls Statistical technique controls
Slide 23-

23 Management Controls Management shall: Establish its policy and objectives for, and commitment to quality… Policy is understood Implemented Maintained at all levels Establish & maintain adequate organizational structure – ensuring that devices are designed & produced in regulatory compliance Establish & maintain appropriate responsibility, authority & interrelations of all personnel… Provide adequate resources… Appoint a Management Representative…
Slide 24-

24 Management Controls (continued) Management shall: Require the Management Representative to review the suitability & effectiveness of the QS at defined intervals to ensure… Establish a quality plan that defines quality practices, resources & activities… Establish how requirements for quality are met. Establish & maintain QS procedures…
Slide 25-

25 Quality System Controls Establish procedures for quality audits … Sufficient personnel with necessary education, background, training & experience to…
Slide 26-

26 Training Controls Establish procedures to identify training needs & ensure all personnel are trained to adequately perform their assigned responsibilities… Personnel shall be made aware of device defects which may occur from improper performance… Personnel performing verification/validation activities shall be made aware of defects & errors that may be encountered…
Slide 27-

27 Design Controls Planning Requirements Specifications Verification Validation Change Control Review Transfer Design History File (DHF)
Slide 28-

28 Design Risk Analysis “Safety requirements should be commensurate with the hazards that can result from a system failure.” FDA expects that all individual hazards, including SW, be identified and either eliminated or reduced to acceptable levels during the device’s design & development FMEAs & Fault Trees
Slide 29-

29 Document & Data Controls Establish & Maintain procedures (EMP) to control ALL documents required by regulations…including Document review, approval & distribution Document changes…
Slide 30-

30 Purchasing Controls EMP to ensure that ALL purchased or otherwise received product & services conform to SPECIFIED REQUIREMENTS…including Evaluation of suppliers, contractors & consultants Establish & maintain data that clearly describe or reference SPECIFIED REQUIREMENTS…including quality requirements
Slide 31-

31 Product ID & Traceability Controls EMP for identifying product during ALL stages of receipt, production, distribution & installation Devices intended for surgical implant, life sustaining or supporting…whose failure when properly used can be expected to result in significant injury shall be identified with a control number…
Slide 32-

32 Process & Manufacturing Controls Manufacturer shall develop, conduct, control & monitor production processes to ensure that a device conforms specifications… Establish & maintain process control procedures that describe all necessary controls…
Slide 33-

33 Production & Process Controls (continued) Process controls shall include: Documented instructions, SOPs, & methods that define & control production Monitoring & control of process parameters, component & device characteristics Compliance with specified standards or codes Approval of processes & equipment Criteria for workmanship expressed in documented standards or by identified & approved samples
Slide 34-

34 Production & Process Controls (continued) EMP to control ALL changes to specifications, methods, processes or procedures… Where environmental conditions can have any adverse effect on product quality…EMP to adequately control those conditions… EMP for health, cleanliness, personnel practices & clothing of personnel…
Slide 35-

35 Production & Process Controls (continued) EMP to prevent contamination of equipment or product… Provide buildings of suitable design & with sufficient space to perform necessary operations, prevent mix-ups & assure orderly handling
Slide 36-

36 Production & Process Controls (continued) Ensure that ALL equipment used in manufacturing process meets its specified requirements… Equipment is properly installed, maintained, adjusted, cleaned & used Establish & maintain schedules for equipment adjustment, cleaning or other maintenance… Conduct periodic inspections Ensure limitations/tolerances are posted
Slide 37-

37 Production & Process Controls (continued) Where manufacturing material could be expected to have adverse effects…EMP for the use & removal of those materials… Validate any computers or automated data processing systems used
Slide 38-

38 Inspection & Testing Controls Manufacturers shall ensure that ALL inspection, measuring & test equipment is suitable & is capable of producing valid results… EMP to ensure equipment is routinely calibrated, inspected, checked & maintained…
Slide 39-

39 Inspection, Measuring & Test Equipment Controls Calibration procedures shall include specific directions & limits for accuracy & precision… Accuracy & precision failures shall require remedial action to reestablish the limits & assess adverse effect(s) on product quality… Calibration standards used shall be traceable… Calibration records shall include equipment ID, dates, individuals, & the next calibration date
Slide 40-

40 Process Validation Where the results of processes cannot be FULLY verified by inspection & test, the process shall be validated according to established procedures EMP to monitor & control validated process parameters, controlling: Personnel, records & changes
Slide 41-

41 Label, Labeling & Packaging EMP to control labeling activities, including label: Integrity Inspection Storage Operations Control number
Slide 42-

42 Packaging Manufacturer shall ensure that packaging & shipping containers are designed & constructed to protect the device from alteration or damage…
Slide 43-

43 Acceptance Controls EMP for inspections, tests or other verifications as acceptance of: Incoming product against specified requirements In-process product against specified requirements Finished devices to ensure EACH production run, lot or batch meets acceptance criteria
Slide 44-

44 Acceptance Controls (continued) Manufacturer shall: Document acceptance activities, including: Activities performed Dates Results Signatures of individuals If appropriate, equipment used Identify acceptance status throughout the processes..
Slide 45-

45 Non-conforming Product Controls EMP to control non-conforming product (NCP) Procedures shall control ID, documentation, evaluation, segregation & disposition of NCP Evaluation shall include determining any need for an investigation & the persons/organizations responsible for the NCP
Slide 46-

46 NCP Controls (continued) EMP that define the responsibility for review & the authority for the disposition of NCP Procedures shall control: Reviews & dispositions Records shall document any justification for use of NCP & signatures of authorizers Rework shall include appropriate retesting, reevaluation & adverse effects assessment to ensure the product meets specifications
Slide 47-

47 Corrective & Preventive Action Controls EMP for implementing CAPAs, including: Analyzing processes, work ops, concessions, audits, records, complaints, returns, & other sources of quality data Use of appropriate statistical methods Investigating nonconformances to product processes & the QS Identifying action(s) needed to correct or prevent recurrence of nonconformances
Slide 48-

48 CAPA Controls (continued) CAPA procedures shall require: Verification or validation of CAPAs to ensure their effectiveness & that they do not adversely affect the finished device Implementing & recording changes in methods & procedures needed to correct & prevent quality problems Ensuring information identified is disseminated to all appropriate individuals Submitting records for management review
Slide 49-

49 Handling, Storage, Preservation& Delivery Controls EMP to: Control storage areas to prevent mix-ups, damage, deterioration, contamination or other adverse effects Control product requiring stock rotation Control receipt from & dispatch to storage areas
Slide 50-

50 Delivery Controls EMP to: Ensure only approved devices are released POs are reviewed to ensure ambiguities & errors are resolved… Ensure stock that deteriorates over time is properly controlled & expired devices are not distributed Maintain distribution records that ID Name & address of initial consignee Date, ID & quantity of devices shipped Any control numbers used
Slide 51-

51 Quality Record Controls All required records shall be maintained at the manufacturing location or other location that is reasonably accessible for FDA inspection, review & copying Records deemed confidential may be so marked All required records shall be retained for the device’s expected life – but in no case less than 2 years from the date of release
Slide 52-

52 Quality Records – Quality System Records (QSR) Manufacturers shall maintain a quality system record (QSR) that includes Procedures and records of activities required by FDA regulation that are not specific to a particular type of device, including: SOP creation & numbering SOPs Training SOPs and records Purchasing SOPs and records Supplier assessment SOPs and records
Slide 53-

53 Quality Records – Device Master Record (DMR) Maintain an approved DMR, including: Device specifications – drawings, composition, formulation, component specifications & SW specifications Product process specifications – equipment specs, production methods, production SOPs & environmental specs QA SOPs, QA specs, acceptance criteria & QA equipment Packaging & labeling specs, & methods Installation, maintenance & servicing SOPs
Slide 54-

54 Quality Records – Device History Record (DHR) EMP that ensure the DHR documents devices were manufactured in accordance with the DMR & FDA regulations, the DHR includes: Date(s) & quantity of manufactured devices Quantity released for distribution Acceptance records Primary ID label & labeling Any device ID & control number(s) used
Slide 55-

55 Installation & Servicing Controls EMP for adequate installation, inspection instructions & any needed test activities Procedures shall ensure proper installation & device performance after installation Installation SOPs shall be distributed appropriately
Slide 56-

56 Installation & Servicing Controls Procedures shall require: Installation personnel perform any required testing in accordance with manufacturers instructions & document the inspection & testing to demonstrate proper installation Specified servicing requirements follow established & maintained SOPs that require servicing meets specified requirements Service reports are analyzed with appropriate statistical methods
Slide 57-

57 Servicing Controls Service reports that represent an event that must be reported to FDA under MDR regulations shall automatically be considered a complaint & handled in accordance with FDA complaint handling regulations Reports shall include: Name, date, ID & any control # of devices serviced Individual performing service & service performed Any test & inspection data
Slide 58-

58 Complaint Handling Controls EMP for: Receiving, reviewing & evaluating complaints by a FORMALLY DESIGNATED UNIT Complaints shall be Processed in a uniform & timely manner Oral (complaints) documented upon receipt Evaluated to determine if complaint represents an MDR event requiring reporting
Slide 59-

59 Complaint Handling Controls (continued) Manufacturers shall: Review & evaluate all complaints to determine if an investigation is necessary If a determination is made that no investigation is required, a record of shall be made that IDs the reason & the individual making the decision
Slide 60-

60 Complaint Handling Controls (continued) Complaints involving device failures to meet ANY specification shall be: Reviewed, evaluated & investigated – unless such investigation has already been performed for a similar complaint & another investigation is unnecessary Documented to show a determination of: Whether the device failed to meet specifications Whether the device was being used for treatment or diagnosis Any relationship to any device to any reported incident or adverse event
Slide 61-

61 Complaint Handling Controls (continued) Complaint investigation records shall include: Device name & date complaint received Device ID & control #s used Name, address & phone # of complainant Nature & details of complaint Dates & results of investigation Any corrective action taken Any reply to complainant
Slide 62-

62 Statistical Technique Controls Where appropriate, EMP for: Identifying valid statistical techniques required for establishing, controlling & verifying the acceptability of process capability and product characteristics Sampling plans, when used, shall be written & based on valid rationale Ensuring sampling methods are adequate for their intended use…
Slide 63-

63 Useful Tools in Understanding GMPs Warning Letters & Recall postings Guidance Documents Compliance Policy Guides (CPGs) Compliance Program Guidance Manual (CPGM) Guidance Documents for Regulated Industry Regulatory Procedures Manual (RPM) Investigations Operations Manual Laboratory Information Bulletins Laboratory Procedures Manual
Slide 64-

64 One Final Note FDA is NOT ALWAYS RIGHT! The Agency is made up of PEOPLE, people with strong convictions & egos The Agency is a bureaucracy & bureaucracies over-reach, over-state, over-react & almost NEVER admit they are wrong The following is an example of a bureaucratic mis-step.
Slide 65-

65 One Final Note (continued) Between 2001 – 2004 Utah Medical was cited by FDA for a number of GMP violations August 2004 FDA sought a Permanent Injunction to stop the firm from manufacturing & distributing medical devices UNTIL the firm DEMONSTRATED corrections in deviations from GMPs "FDA will not tolerate manufacturing practices that can potentially put patients at risk," said FDA Acting Commissioner Dr. Lester M. Crawford
Slide 66-

66 One Final Note (continued) FDA’s injunction followed three years of FDA inspections that FDA claimed “revealed a pattern of significant deviations from the Quality System regulation at Utah Medical's Midvale facility.” FDA claimed “Utah Medical has consistently failed to ensure that its products are manufactured in accordance with the Quality System regulation.”
Slide 67-

67 One Final Note (continued) On Oct 21, 2005 Federal Judge Bruce Jenkins found & stated “This is an unusual case. The safety of the products manufactured by Utah Medical has never been at issue.”
Slide 68-

68 One Final Note (continued) The judge noted that “Even though product safety is a non-issue, the relief originally sought by the United States was to stop Utah Medical’s products from entering commerce because of alleged persistent deficiencies of Utah Medical in complying with the applicable quality system regulations (21 CFR § 820), and asserting that a failure to comply by definition produced an adulterated product and subjected the product and the persons responsible for the product to regulatory action.”
Slide 69-

69 One Final Note (continued) Judge Jenkins went on to state “In short, the United States asked that Utah Medical be ordered to stop the sale of product until Utah Medical complies with the regulation 21 CFR § 820 and in a manner that has been found acceptable to FDA.” Further he stated “The court has been impressed as well by Utah Medical’s design of product, its record-keeping of each step along the way, the acceptance in the market of its products, the Company’s uniform processing of complaints, and the manner in which change is made in practice and procedure as a result of complaint handling.”
Slide 70-

70 One Final Note (continued) Judge Jenkins concluded “It makes no sense for the court to order Utah Medical to do something they are already doing.” The Court disagreed with all allegations by the FDA, and dismissed the lawsuit filed in August 2004 that sought to shut down UTMD, without any evidence of unsafe, ineffective, or defective products or products causing any patient harm, until UTMD complied with the FDA’s interpretation of the QSR, an interpretation that was never provided to UTMD until after the lawsuit was filed
Slide 71-

71 One Final Note ( continued) The U.S. Federal District Court in Salt Lake City confirmed that UTMD is operating in compliance with 21 CFR § 820, the U.S. Food & Drug Administration (FDA) Quality System Regulation (QSR).
Slide 72-

72 Questions ?
Slide 73-

73 Abbreviations Used § - Paragraph APIs - Active pharmaceutical ingredients CAPA – Corrective Action & Preventive Action CBER – Center for Biologics Research & Development CDER – Center for Drug Evaluation & Research CDRH – Center for Devices & Radiologic Health CVM – Center for Veterinary Medicine CFR – Code of Federal Regulations cGMP – Current Good Manufacturing Practice CPGs – Compliance Policy Guides CPGM – Compliance Program Guidance Manual DHF – Design History File DHR – Device History Record DMR – Device Master Record FDA – Food & Drug Administration FDA – Food & Drug Administration FFDC or FFD&C – Federal Food Drug & Compliance (Act) FMEA – Failure Mode & Effects Analysis EMP – Establish & maintain procedures GMP – Good Manufacturing Practice ID - Identification ISO – Acronym for International Standards Organization OTC – Over the Counter NCP – Nonconforming Product QA – Quality Assurance QS – Quality System QSR – Quality System Regulation SOP – Standard Operating Procedure UTMD – Utah Medical Device